Closed
SectorHealthcare
3.6 0.56
24h
Min
3.49
Max
3.66
Income | -16M 3M |
---|---|
Sales | -13M 46M |
P/E Sector Avg | 4.597 39.564 |
Profit margin | 6.464 |
Employees | 172 |
EBITDA | -14M 4M |
Recommendations | Sell |
---|---|
12 Months Forecast | -16.43% downside |
Next Earnings | 31 lip 2025 |
---|
Market Cap | 18M 178M |
---|---|
Previous open | 3.04 |
Previous close | 3.6 |
By Acuity
25%
75%
49 / 376 Ranking in Healthcare
By Trading Central
Confidence
Weak Bullish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 3 USD -16.43%
High 4 USD
Low 2 USD
Based on 2 Wall Street analysts offering 12 month price targets forPuma Biotechnology Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Very Strong Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$